In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved.
Category: Channels
HCA hospital 'failed to protect' NICU patients: Report
After an HCA Healthcare hospital discovered fractures on four infant patients in 2023, the Virginia health department found reporting deficiencies, and in 2024, three more infants had similar fractures, according to The Washington Post.
Where ASCs are contracting
The state of Washington lost the most ASCs over the last two years and seven other states reported losses since December 2022, according to CMS data.
11 states adding the most ASCs
The number of ASCs across the U.S. is growing, and particularly so in California, Florida and Georgia.
5 emerging specialties among ASCs
Several specialties, traditionally believed to be mainstays of the hospital setting, are moving significantly toward ASCs, according to L.E.K. Consulting’s “2024 ASC Insights Study.”
Dementia to double by 2060: 4 study notes
The number of U.S. adults with dementia is expected to double, from 514,000 in 2020 to 1 million in 2060, according to a study published Jan. 13 in Nature Medicine.
Latest inaugural leadership roles at 6 hospitals, systems
As hospitals and health systems navigate the care market, their leadership structures evolve to encompass the addition of first-time C-suite roles.
Respiratory virus activity remains elevated: 7 key updates
Respiratory illness activity remains high across the U.S., with emergency department visits and positive test rates rising for COVID-19, influenza and respiratory syncytial virus.
FDA to weigh approval of pain pill billed as opioid alternative
The FDA is set to consider approval of an alternative to opioids developed by Vertex Pharmaceuticals, The Washington Post reported Jan. 13.
J&J set to acquire drugmaker for $14.6B
Johnson & Johnson is set to acquire Intra-Cellular Therapies for $14.6 billion.
